175 related articles for article (PubMed ID: 27800558)
1. High-Throughput Excipient Discovery Enables Oral Delivery of Poorly Soluble Pharmaceuticals.
Ting JM; Tale S; Purchel AA; Jones SD; Widanapathirana L; Tolstyka ZP; Guo L; Guillaudeu SJ; Bates FS; Reineke TM
ACS Cent Sci; 2016 Oct; 2(10):748-755. PubMed ID: 27800558
[TBL] [Abstract][Full Text] [Related]
2. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
Widanapathirana L; Tale S; Reineke TM
Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
[TBL] [Abstract][Full Text] [Related]
3. Solution-state polymer assemblies influence BCS class II drug dissolution and supersaturation maintenance.
Dalsin MC; Tale S; Reineke TM
Biomacromolecules; 2014 Feb; 15(2):500-11. PubMed ID: 24328187
[TBL] [Abstract][Full Text] [Related]
4. Deconstructing HPMCAS: Excipient Design to Tailor Polymer-Drug Interactions for Oral Drug Delivery.
Ting JM; Navale TS; Jones SD; Bates FS; Reineke TM
ACS Biomater Sci Eng; 2015 Oct; 1(10):978-990. PubMed ID: 33429529
[TBL] [Abstract][Full Text] [Related]
5. Diblock Terpolymers Are Tunable and pH Responsive Vehicles To Increase Hydrophobic Drug Solubility for Oral Administration.
Tale S; Purchel AA; Dalsin MC; Reineke TM
Mol Pharm; 2017 Nov; 14(11):4121-4127. PubMed ID: 28937226
[TBL] [Abstract][Full Text] [Related]
6. Critical Excipient Properties for the Dissolution Enhancement of Phenytoin.
Johnson LM; Hillmyer MA
ACS Omega; 2019 Nov; 4(21):19116-19127. PubMed ID: 31763534
[TBL] [Abstract][Full Text] [Related]
7. Poly(vinylpyridine-
Liu YS; Della Rocca J; Schenck L; Koynov A; Sifri RJ; Winston MS; Frank DS
Mol Pharm; 2024 Mar; 21(3):1182-1191. PubMed ID: 38323546
[TBL] [Abstract][Full Text] [Related]
8. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
9. Aggregated Solution Morphology of Poly(acrylic acid)-Poly(styrene) Block Copolymers Improves Drug Supersaturation Maintenance and Caco-2 Cell Membrane Permeation.
Purchel AA; Boyle WS; Reineke TM
Mol Pharm; 2019 Nov; 16(11):4423-4435. PubMed ID: 31633362
[TBL] [Abstract][Full Text] [Related]
10. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.
Hugo M; Kunath K; Dressman J
Drug Dev Ind Pharm; 2013 Feb; 39(2):402-12. PubMed ID: 22591213
[TBL] [Abstract][Full Text] [Related]
11. Automated PET-RAFT Polymerization Towards Pharmaceutical Amorphous Solid Dispersion Development.
Upadhya R; Punia A; Kanagala MJ; Liu L; Lamm M; Rhodes TA; Gormley AJ
ACS Appl Polym Mater; 2021 Mar; 3(3):1525-1536. PubMed ID: 34368765
[TBL] [Abstract][Full Text] [Related]
12. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery.
Ting JM; Porter WW; Mecca JM; Bates FS; Reineke TM
Bioconjug Chem; 2018 Apr; 29(4):939-952. PubMed ID: 29319295
[TBL] [Abstract][Full Text] [Related]
13. High-throughput kinetic turbidity analysis for determination of amorphous solubility and excipient screening for amorphous solid dispersions.
Fan Y; Castleberry S
Int J Pharm; 2023 Jan; 631():122495. PubMed ID: 36526147
[TBL] [Abstract][Full Text] [Related]
14. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.
Butreddy A
Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180
[TBL] [Abstract][Full Text] [Related]
15. Role of Polymer Excipients in the Kinetic Stabilization of Drug-Rich Nanoparticles.
Van Zee NJ; Hillmyer MA; Lodge TP
ACS Appl Bio Mater; 2020 Oct; 3(10):7243-7254. PubMed ID: 35019383
[TBL] [Abstract][Full Text] [Related]
16. Multiscale Computational Modeling of the Nanostructure of Solid Dispersions of Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) and Phenytoin.
Huang W; Mandal T; Larson RG
Mol Pharm; 2017 Oct; 14(10):3422-3435. PubMed ID: 28829134
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers.
Ojo AT; Ma C; Lee PI
Int J Pharm; 2020 Dec; 591():120005. PubMed ID: 33132149
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Performance of Blended Polymer Excipients in Delivering a Hydrophobic Drug through the Synergistic Action of Micelles and HPMCAS.
Li Z; Johnson LM; Ricarte RG; Yao LJ; Hillmyer MA; Bates FS; Lodge TP
Langmuir; 2017 Mar; 33(11):2837-2848. PubMed ID: 28282137
[TBL] [Abstract][Full Text] [Related]
19. Hydrogenated phospholipid, a promising excipient in amorphous solid dispersions of fenofibrate for oral delivery: Preparation and in-vitro biopharmaceutical characterization.
Czajkowski M; Jacobsen AC; Bauer-Brandl A; Brandl M; Skupin-Mrugalska P
Int J Pharm; 2023 Sep; 644():123294. PubMed ID: 37544387
[TBL] [Abstract][Full Text] [Related]
20. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
Chavan RB; Lodagekar A; Yadav B; Shastri NR
Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
